Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Celldex Therapeutics | 9 | 1 | 0 | 0 | €34.00 | €51.20 | 50.581% |
MannKind Corp. | 7 | 0 | 0 | 0 | €3.90 | €6.42 | 64.594% |
Cara Therapeutics Inc. | 8 | 1 | 2 | 0 | €0.64 | €4.63 | 625.596% |
Haemonetics Corp. | 7 | 0 | 1 | 0 | €80.50 | €97.90 | 21.617% |
Universal Health Services B | 9 | 3 | 2 | 1 | €154.00 | €159.70 | 3.704% |
Precision BioSciences Inc | 6 | 0 | 1 | 0 | €0.35 | €2.81 | 706.293% |
Cocrystal Pharma Inc. | 6 | 0 | 1 | 0 | €1.39 | €10.08 | 625.036% |
Deciphera Pharmaceuticals | 6 | 0 | 1 | 0 | €13.20 | €21.53 | 63.100% |
Immunogen Inc. | 6 | 0 | 0 | 0 | €28.97 | - | - |
Bruker Corp. | 7 | 1 | 0 | 1 | €75.64 | €85.68 | 13.279% |
US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €95.50 | €108.77 | 13.894% |
Patterson Companies Inc. | 6 | 0 | 0 | 0 | €24.20 | €32.18 | 32.984% |
West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €336.70 | €369.72 | 9.808% |
Akebia Therapeutics Inc. | 8 | 3 | 2 | 1 | €1.25 | €3.60 | 188.389% |
Glycomimetics Inc. | 5 | 0 | 0 | 0 | €1.53 | €7.35 | 381.126% |
Personalis Inc | 5 | 0 | 1 | 0 | €1.18 | €3.23 | 173.164% |
Evolus Inc | 6 | 1 | 1 | 1 | €10.90 | €20.26 | 85.829% |
Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €29.60 | €38.99 | 31.718% |
Masimo Corp. | 6 | 1 | 1 | 0 | €127.20 | €147.62 | 16.050% |
Eledon Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €1.82 | €12.09 | 564.253% |
Syros Pharmaceuticals Inc. | 5 | 1 | 3 | 1 | €4.70 | €12.80 | 172.372% |
X4 Pharmaceuticals, Inc. | 4 | 0 | 1 | 0 | €1.09 | €2.76 | 153.003% |
Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €46.58 | €70.00 | 50.295% |
Kala Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €6.00 | €19.86 | 231.082% |
Chemed Corp. | 4 | 0 | 0 | 0 | €565.00 | €588.14 | 4.096% |